What is new in the treatment of multiple sclerosis?
- 1 March 2000
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 59 (3) , 401-410
- https://doi.org/10.2165/00003495-200059030-00002
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A Double‐Blind, Placebo‐Controlled, Randomized Trial of Cladribine in Relpaasing‐Remitting Multiple SclerosisProceedings of the Association of American Physicians, 1999
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Long Term Treatments I 5 November 1997, TuesdayMultiple Sclerosis Journal, 1997
- Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in PathogenesisBrain Pathology, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- The interferons: Biological effects, mechanisms of action, and use in multiple sclerosisAnnals of Neurology, 1995
- The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosisThe Lancet, 1991
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple SclerosisNew England Journal of Medicine, 1987
- Intensive Immunosuppression in Progressive Multiple SclerosisNew England Journal of Medicine, 1983